Although our data explained in partly the mechanisms of IBP-mediated suppression of breast cancer cell apoptosis in response to cisplatin, whether this function is related to RhoGTPase (e.g. Cdc42) is still unknown. Here, CDC42 is linked to breast carcinoma.